At a glance
ClinicalIndex Comparison Record- ✓3 or more outpatient COPD clinic visits in the 2 years prior to enrollment, OR hospitalization with primary COPD discharge diagnosis in the 2 years prior, OR active use of inhaled beta-agonist and ipratropium bromide (or combination inhalers like Combivent) in the 12 months prior
- ✓Scheduled future visit in an eligible primary care or chest clinic
- ✓Confirmed airflow limitation
- ✕Cognitive dysfunction, language barriers, or severe psychiatric disorder that would preclude completion of questionnaires
- ✕Patient's COPD provider does not participate in the study
- ✕New COPD diagnosis within the last month
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Improving the Quality of End-of-Life Communication for Patients With COPD
In Brief
A clinical study evaluating Audit and Feedback for Pulmonary Disease and 3 related conditions. Completed, enrolled 376 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate a multifaceted intervention to improve the quality of end-of-life communication between patients with COPD and their primary care providers using information about patients preferences for end of life care and how to communicate and use this information to activate patients, family members, and healthcare providers.
Study Details
Timeline
Interventions
Intervention patients and clinicians received a one-page patient-specific individualized summary, based on questionnaire responses, to stimulate conversations.